NEWS

As the global healthcare and life sciences sectors continue to evolve, Haier Biomedical receives widespread acclaim with our commitment to technological innovation and high-quality service. From August to September 2024, we will actively participate in a series of prestigious exhibitions at renowned universities across the United States. Join us as we showcase our exceptional products and solutions in life sciences and healthcare, further demonstrating our dedication to advancing the field and meeting the needs of our global market.

In the rapidly evolving fields of global life sciences, biotechnology, and biopharmaceuticals, Haier Biomedical is at the forefront, steering with advanced technology and leading a new era of biospecimen storage. As an industry pioneer, Haier Biomedical is accelerating its global expansion, leveraging exceptional technological strength and a forward-looking strategy to provide clients worldwide with highly efficient and secure biospecimen management solutions.

We are delighted to announce that Haier Biomedical has been officially approved as a supplier on the NHS Supply Chain Pathology Framework, which will run from 2024 to 2028. This achievement marks a significant milestone for our company and underscores our commitment to delivering high-quality laboratory equipment and services to the healthcare sector.

The INTERPHEX Week Tokyo, held from June 26 to 28, 2024, drew international interest from the medical and pharmaceutical domains. As a leading-edge comprehensive platform in Asia for the pharmaceutical and cosmetics sectors, INTERPHEX Week Tokyo boasts a history spanning over two decades. Comprising four distinct exhibitions focusing on pharmaceuticals, life sciences, medical devices, and beyond, this event unites experts across diverse industries and ranks among Japan's premier professional expos.

On June 18, at the Haier Group's Healthcare Industry Ecosystem Integration Conference, with the theme "Shaping Tomorrow, Advancing Health," took place in Shanghai. We are delighted to welcome Shanghai RAAS as a new addition to the Haier ecosystem and embark on exploring the boundless opportunities within the healthcare sector together.

On March 27, Haier Biomedical released its 2023 Sustainability Report (hereinafter referred to as the "Report"), disclosing the company's practices in the economic, environmental, social, and corporate governance responsibilities. In 2023，based on the sustainable development vision of "Intelligence Enlightens Life for a Shared Future," Haier Biomedical actively engaged with the United Nations Global Compact and developed our "LIFE" sustainability model，focusing on the four fundamental pillars of our approach: Leadership, Integrity, Future, and Ecosystem. By innovation, intelligence, green transformation and advancement, we contributes to society with concrete actions.

Haier Biomedical recently delivered a large cryogenic storage system to support multiple myeloma research at the Botnar Institute for Musculoskeletal Sciences in Oxford. This institute is Europe's largest center for studying musculoskeletal conditions, boasting state-of-the-art facilities and a team of 350 staff and students. The cryogenic storage facility, a part of this infrastructure, attracted the Oxford Centre for Translational Myeloma Research, aiming to centralize its tissue samples.

In an era marked by rapid advancements in the biomedical industry and the increasing globalization of enterprises, Haier Biomedical emerges as a beacon of innovation and excellence. As a foremost international leader in life sciences, the brand stands at the forefront of medical innovation and digital solutions, dedicated to safeguarding and enhancing life and health worldwide. With a relentless commitment to technological advancement, Haier Biomedical not only serves the needs of the life sciences and medical sectors but also proactively adapts to the evolving landscape. By embracing change, forging new pathways, and seizing emerging opportunities, the brand continually enhances its competitiveness and drives transformative progress both within and beyond its realm.